Landscape study on patent filing – CAR T-cell Immunotherapy

This study commissioned by the European Patent Office demonstrates the application of patent information to gain insights into specific technological fields, in this case Chimeric Antigen Receptor T-cell Immunotherapy (CAR T-cell Immunotherapy).

If you are interested in finding out more about patents in the field of CAR T-cell immunotherapy, a highly topical subject in cancer research, please find the link to the complete document here.